ArticleCells2022

Pilot Study of the Effects of Chronic Intracerebroventricular Infusion of Human Anti-IgLON5 Disease Antibodies in Mice.

Sara Alvente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.